|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
51,620,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.000001 - $0.1993 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Humanigen is a biopharmaceutical company focused on developing its immuno-oncology and immunology portfolio of monoclonal antibodies. Co. is focusing on the development of its key product candidate, lenzilumab, its Humaneered® anti-human GM-CSF immunotherapy, through a clinical research agreement to study the effect of lenzilumab on the safety of Yescarta®, axicabtagene ciloleucel including cytokine release syndrome, and neurotoxicity. Co. is creates combinatory gene-edited CAR-T therapies to improve efficacy. Co. is also developing its own chimeric antigen receptor T-cell programs based on the backbone of ifabotuzumab and HGEN005, in unmet medical need and rare/orphan oncology conditions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,042,996 |
Total Buy Value |
$0 |
$0 |
$0 |
$2,263,990 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
0 |
0 |
386,350 |
386,350 |
Total Sell Value |
$0 |
$0 |
$4,250 |
$4,250 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
1 |
1 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Nomis Bay Ltd. |
10% Owner |
|
2020-07-20 |
4 |
S |
$5.00 |
$1,309,575 |
D/D |
(261,915) |
32,689,270 |
|
60% |
|
Nomis Bay Ltd. |
10% Owner |
|
2020-07-17 |
4 |
S |
$5.01 |
$190,615 |
D/D |
(38,085) |
32,951,185 |
|
62% |
|
Nomis Bay Ltd. |
10% Owner |
|
2020-06-30 |
4 |
S |
$4.91 |
$14,739 |
D/D |
(3,000) |
32,989,270 |
|
65% |
|
Nomis Bay Ltd. |
10% Owner |
|
2020-06-16 |
4 |
S |
$5.73 |
$200,652 |
D/D |
(35,000) |
32,992,270 |
|
57% |
|
Nomis Bay Ltd. |
10% Owner |
|
2020-06-15 |
4 |
S |
$5.50 |
$165,147 |
D/D |
(30,000) |
33,027,270 |
|
55% |
|
Nomis Bay Ltd. |
10% Owner |
|
2020-06-10 |
4 |
S |
$3.48 |
$17,385 |
D/D |
(5,000) |
33,057,270 |
|
26% |
|
Nomis Bay Ltd. |
10% Owner |
|
2020-06-09 |
4 |
S |
$3.65 |
$127,785 |
D/D |
(35,000) |
33,062,270 |
|
28% |
|
Nomis Bay Ltd. |
10% Owner |
|
2020-06-04 |
4 |
S |
$3.03 |
$320,650 |
D/D |
(106,000) |
33,097,270 |
|
1% |
|
Nomis Bay Ltd. |
10% Owner |
|
2020-06-03 |
4 |
S |
$2.98 |
$301,313 |
D/D |
(101,010) |
33,203,270 |
|
2% |
|
Nomis Bay Ltd. |
10% Owner |
|
2020-06-02 |
4 |
S |
$2.18 |
$574,148 |
D/D |
(263,250) |
33,304,280 |
|
5% |
|
Barliant Ronald |
|
|
2020-05-20 |
4 |
A |
$0.86 |
$23,088 |
D/D |
26,847 |
449,351 |
|
- |
|
Black Horse Capital Management Llc |
|
|
2020-04-02 |
4 |
OE |
$0.36 |
$570,000 |
I/I |
1,583,333 |
49,636,917 |
|
- |
|
Boehm Rainer J. |
|
|
2020-04-01 |
4 |
A |
$1.20 |
$16,500 |
D/D |
13,750 |
417,338 |
|
- |
|
Buxton Cheryl |
|
|
2020-04-01 |
4 |
A |
$1.20 |
$12,989 |
D/D |
10,824 |
15,400 |
|
- |
|
Nomis Bay Ltd. |
10% Owner |
|
2020-03-20 |
4 |
S |
$2.00 |
$12,000 |
D/D |
(6,000) |
33,567,530 |
|
-913% |
|
Buxton Cheryl |
|
|
2020-01-22 |
4 |
A |
$0.38 |
$1,739 |
D/D |
4,576 |
4,576 |
|
- |
|
Boehm Rainer J. |
|
|
2020-01-22 |
4 |
A |
$0.38 |
$16,500 |
D/D |
43,421 |
403,588 |
|
- |
|
Boehm Rainer J. |
|
|
2019-11-08 |
4 |
A |
$0.70 |
$16,500 |
D/D |
23,571 |
360,167 |
|
- |
|
Boehm Rainer J. |
|
|
2019-07-29 |
4 |
A |
$0.85 |
$16,500 |
D/D |
19,412 |
336,596 |
|
- |
|
Barliant Ronald |
|
|
2019-07-29 |
4 |
A |
$0.85 |
$13,500 |
D/D |
15,882 |
422,504 |
|
- |
|
Durrant Cameron |
Chief Executive Officer |
|
2019-06-04 |
4 |
A |
$1.25 |
$10,000 |
D/D |
8,000 |
557,207 |
|
- |
|
Black Horse Capital Management Llc |
10% Owner |
|
2019-05-31 |
4 |
A |
$0.00 |
$0 |
I/I |
1,177,275 |
48,053,584 |
|
- |
|
Barliant Ronald |
|
|
2019-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
236,499 |
406,622 |
|
- |
|
Durrant Cameron |
Chief Executive Officer |
|
2019-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
235,624 |
549,207 |
|
- |
|
Boehm Rainer J. |
|
|
2019-05-29 |
4 |
A |
$0.67 |
$158,686 |
D/D |
238,625 |
317,184 |
|
- |
|
160 Records found
|
|
Page 4 of 7 |
|
|